Medicare Enrolled

Dr. Alan Manevitz, M.D.

Psychiatry · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Mixed engagement
60 SUTTON PL S STE 1CN, New York, NY 10022
2127515072
In practice since 2007 (19 years)
NPI: 1093860975 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Manevitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manevitz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Manevitz

Dr. Alan Manevitz is a psychiatry specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Manevitz performed 3,994 Medicare services across 438 unique beneficiaries.

Between the years covered by Open Payments, Dr. Manevitz received a total of $7,667 from 22 pharmaceutical and/or device companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Manevitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in NY $7,667 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,994
Medicare services
Top 1% in NY for psychiatry
438
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~210 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
 1,475 $72 $98
Magnetic field treatment to stimulate brain nerve cells
A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment.
 829 $163 $400
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 778 $73 $107
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 766 $108 $147
Family psychotherapy, 50 minutes
A 50-minute therapy session involving the patient and their family members to address psychological or behavioral concerns.
 81 $81 $120
Family psychotherapy without patient, 50 minutes
A 50-minute psychotherapy session conducted with family members in the absence of the patient.
 25 $77 $105
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
 24 $157 $325
Magnetic field treatment to stimulate brain nerve cells, initial delivery
A procedure that uses a magnetic field to stimulate nerve cells in the brain. This code covers the initial delivery and management of the treatment.
 16 $283 $500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,667
Total received (2018-2024)
Avg $1,095/year across 7 years
Top 8% in NY for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
171
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$4,121 (53.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,381 (44.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$164 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$438
2023
$4,530
2022
$320
2021
$967
2020
$242
2019
$721
2018
$448

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alkermes, Inc.
$90
ABBVIE INC.
$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$80
Lundbeck LLC
$47
Janssen Pharmaceuticals, Inc
$34
Teva Pharmaceuticals USA, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$28
Otsuka America Pharmaceutical, Inc.
$25
Almatica Pharma LLC
$22
Top 3 companies account for 57.1% of 2024 payments
All-time payments by company (2018-2024) ›
Neuronetics, Inc.
$4,463
AbbVie Inc.
$523
ABBVIE INC.
$414
Takeda Pharmaceuticals U.S.A., Inc.
$402
Vanda Pharmaceuticals Inc.
$308
ITI, Inc.
$221
Allergan Inc.
$195
Allergan, Inc.
$159
Janssen Pharmaceuticals, Inc
$150
Bausch Health US, LLC
$141
Supernus Pharmaceuticals, Inc.
$120
Lundbeck LLC
$103
Otsuka America Pharmaceutical, Inc.
$93
Alkermes, Inc.
$90
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$80
Almatica Pharma LLC
$46
Sunovion Pharmaceuticals Inc.
$45
Teva Pharmaceuticals USA, Inc.
$32
Neurocrine Biosciences, Inc.
$29
JAZZ PHARMACEUTICALS INC.
$24
LivaNova USA, Inc.
$17
Ironshore Pharmaceuticals Inc.
$11
Top 3 companies account for 70.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · APLENZIN · ARISTADA · Austedo XR · BRINTELLIX · CAPLYTA · Fanapt · HETLIOZ · Hetlioz · INGREZZA · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · QELBREE · REXULTI · SERTRALINE HCL · SPRAVATO · SUNOSI · TRINTELLIX · Trintellix · UBRELVY · VNS - Symmetry · VRAYLAR · VYVANSE · WELLBUTRIN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 8% for psychiatry in NY.

Looking for a psychiatry specialist in New York?
Compare psychiatrists in the New York area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
5,026
Per 100K population
308.8
County median income
$104,553
Nearest hospital
NEW YORK-PRESBYTERIAN HOSPITAL
0.5 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Manevitz is a clinical cardiology specialist, with above-average Medicare volume (top 1% in NY), with mixed engagement industry engagement in the top 8% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Manevitz experienced with 45-minute psychotherapy and evaluation visit?
Based on Medicare claims data, Dr. Manevitz performed 1,475 45-minute psychotherapy and evaluation visit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Manevitz receive payments from pharmaceutical companies?
Yes. Dr. Manevitz received a total of $7,667 from 22 companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manevitz's costs compare to other psychiatrists in New York?
Dr. Manevitz's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manevitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in New York
Browse psychiatrists in New York ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in NY
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in NY
Which NY psychiatrists receive the most from drug and device companies.
By company
Neuronetics, Inc. Payments to Doctors
See all physicians who received payments from Neuronetics, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →